Pritelivir

Active substance   Pritelivir
Holder myTomorrows
Status Rnning
Indication treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient
Public documents Approbation
  Information for the patient
  Consentement éclairé
Last update 28/07/2022

 

Last updated on 28/09/2022